Intacoxia 60mg Tablet contains Etoricoxib, a selective COX-2 inhibitor belonging to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). It is primarily indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. Etoricoxib exerts its therapeutic effect by selectively inhibiting the cyclooxygenase-2 enzyme, thereby reducing the synthesis of prostaglandins involved in inflammation and pain without significantly affecting COX-1, which helps minimize gastrointestinal adverse effects commonly seen with traditional NSAIDs. Intacoxia is administered orally, with a recommended dosage tailored according to the severity of symptoms and patient response, typically once daily. It is contraindicated in patients with known hypersensitivity to Etoricoxib or other NSAIDs, active peptic ulcer disease, severe hepatic or renal impairment, and established cardiovascular diseases. Caution is advised in patients with hypertension, heart failure, or those at risk of thrombotic events. Common side effects include headache, dizziness, gastrointestinal discomfort, and elevated liver enzymes. Regular monitoring of renal and hepatic function is recommended during prolonged therapy. Intacoxia 60mg provides effective symptomatic relief in inflammatory conditions while offering a favorable gastrointestinal safety profile compared to non-selective NSAIDs.